Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digitoxin for Cystic Fibrosis
NCT00782288Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Aug 2010
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of digitoxin in cystic fibrosis (CF), sponsored by National Jewish Health. Started Aug 2010; status: completed.
02
Drugs
digitoxin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00782288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782288.